Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial

TitleWho seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial
Publication TypeJournal Article
Year of Publication2004
AuthorsRoberts, J. S., Barber, M., Brown, T. M., Cupples, A. L., Farrer, L. A., LaRusse, S. A., Post, S. G., Quaid, K. A., Ravdin, L. D., Relkin, N. R., Sadovnick, D. A., Whitehouse, P. J., Woodard, J. L., & Green, R. C.
JournalGenetics in medicine : official journal of the American College of Medical Genetics
Volume6
Issue4
Pagination197-203
Date Published2004 Jul-Aug
ISSN1098-3600
KeywordsAdult, Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Female, Genetic Counseling, Genetic Predisposition to Disease, Genetic Testing, Genotype, Humans, Male, Middle Aged
Abstract

Alzheimer's disease, for which one form of the apolipoprotein E (APOE) genotype is a risk factor, provides a paradigm in which to examine response to susceptibility testing for common, complex diseases. This study's main purposes were to estimate interest in such testing and to examine demographic predictors of study participation.

Alternate JournalGenet. Med.